Nexus AG: strong sales and earnings increase in the first half-year 2025

Donaueschingen (pta007/12.08.2025/08:45 UTC+2)

12 August 2025: Nexus AG, one of the leading European suppliers of software solutions in the healthcare sector, was able to increase its sales by approx. 10% and EBIT by approx. 33% in the first six months of 2025. As a result, the continually positive development of sales and earnings of the last years could be continued.
Sales improved from KEUR 127,665 to KEUR 140,763 (+10.3%) in the first half-year 2025. The international share of total business volume was 39.5% (6M-2024: 44.1%) and amounted to KEUR 55,632 compared to KEUR 56,233 (6M-2024).

The consolidated earnings before taxes (EBT) increased by 33.0% to KEUR 22,515 (6M-2024: KEUR 16,935), EBIT rose very sharply by 32.8% from KEUR 16,410 (6M-2024) to KEUR 21,797. Consolidated surplus rose by 25.9% to KEUR 15,590 (6M-2024: 12,382 KEUR), and EBITDA increased by 22.8% to KEUR 31,239 (6M-2024: KEUR 25,448). Operating cash increased by 34.3% to KEUR 37,089 in the first six months (6M-2024: KEUR 27,611).
As of 30/06/2025, the company had cash resources at its disposal in the amount of KEUR 136,819 (31/12/2024: KEUR 114,038). Excluding the companies acquired in the first half of 2025, the increase in sales would have been 9.5% and the increase in EBITDA would have been 24.4%. KEUR 1,674 was spent on the integration of the acquired companies in the first half of 2024, which was recognised in earnings. Nexus AG had equity capital amounting to KEUR 297,396 as of 30/06/2025 (31/12/2024: KEUR 282,958). Consequently, the equity capital rate is 62.2% (31/12/2024: 64.6%).

Donaueschingen, August 12th 2025

The Managing Board

(end)

Emitter:	Nexus AG Irmastraße 1 78166 Donaueschingen Germany
Contact Person:	Hannes Wehinger
Phone:	+49 771 22960-260
E-Mail:	ir@nexus-ag.de
Website:	www.nexus-ag.de
ISIN(s):	DE0005220909 (Share)
Stock Exchange(s):	Regulated Market in Frankfurt; Free Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate